source
- J&J reports 40% Q2 sales jump for Spravato as psychedelic rivals loomJohnson & Johnson said its depression nasal spray Spravato generated $584 million in worldwide revenue in the second quarter, a 40% increase from a year earlier. The company highlighted the drug as…
- B. Braun pulls spinal anesthesia kits after recall of bupivacaine in dextrose injectionB. Braun Medical, Inc. has issued a recall of several spinal anesthesia convenience kits that contain Huons bupivacaine hydrochloride in dextrose injection. The recall follows a request from Huons…